Literature DB >> 21865265

Angiotensin receptor blockers shift the circadian rhythm of blood pressure by suppressing tubular sodium reabsorption.

Michio Fukuda1, Tamaki Wakamatsu-Yamanaka, Masashi Mizuno, Toshiyuki Miura, Tatsuya Tomonari, Yoko Kato, Tadashi Ichikawa, Sota Miyagi, Yuichi Shirasawa, Akinori Ito, Atsuhiro Yoshida, Genjiro Kimura.   

Abstract

Recently, we found that an angiotensin II receptor blocker (ARB) restored the circadian rhythm of the blood pressure (BP) from a nondipper to a dipper pattern, similar to that achieved with sodium intake restriction and diuretics (Fukuda M, Yamanaka T, Mizuno M, Motokawa M, Shirasawa Y, Miyagi S, Nishio T, Yoshida A, Kimura G. J Hypertens 26: 583-588, 2008). ARB enhanced natriuresis during the day, while BP was markedly lower during the night, resulting in the dipper pattern. In the present study, we examined whether the suppression of tubular sodium reabsorption, similar to the action of diuretics, was the mechanism by which ARB normalized the circadian BP rhythm. BP and glomerulotubular balance were compared in 41 patients with chronic kidney disease before and during ARB treatment with olmesartan once a day in the morning for 8 wk. ARB increased natriuresis (sodium excretion rate; U(Na)V) during the day (4.5 ± 2.2 to 5.5 ± 2.1 mmol/h, P = 0.002), while it had no effect during the night (4.3 ± 2.0 to 3.8 ± 1.6 mmol/h, P = 0.1). The night/day ratios of both BP and U(Na)V were decreased. The decrease in the night/day ratio of BP correlated with the increase in the daytime U(Na)V (r = 0.42, P = 0.006). Throughout the whole day, the glomerular filtration rate (P = 0.0006) and tubular sodium reabsorption (P = 0.0005) were both reduced significantly by ARB, although U(Na)V remained constant (107 ± 45 vs. 118 ± 36 mmol/day, P = 0.07). These findings indicate that the suppression of tubular sodium reabsorption, showing a resemblance to the action of diuretics, is the primary mechanism by which ARB can shift the circadian BP rhythm into a dipper pattern.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21865265     DOI: 10.1152/ajprenal.00167.2011

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  16 in total

Review 1.  Advances in understanding the peripheral circadian clocks.

Authors:  Jacob Richards; Michelle L Gumz
Journal:  FASEB J       Date:  2012-06-01       Impact factor: 5.191

Review 2.  Mechanism of the circadian clock in physiology.

Authors:  Jacob Richards; Michelle L Gumz
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-04-10       Impact factor: 3.619

3.  Effect of dipeptidyl peptidase-4 inhibition on circadian blood pressure during the development of salt-dependent hypertension in rats.

Authors:  Abu Sufiun; Kazi Rafiq; Yoshihide Fujisawa; Asadur Rahman; Hirohito Mori; Daisuke Nakano; Hiroyuki Kobori; Koji Ohmori; Tsutomu Masaki; Masakazu Kohno; Akira Nishiyama
Journal:  Hypertens Res       Date:  2015-01-15       Impact factor: 3.872

4.  The angiotensin II type 1 receptor blocker olmesartan preferentially improves nocturnal hypertension and proteinuria in chronic kidney disease.

Authors:  Mai Yanagi; Kouichi Tamura; Tetsuya Fujikawa; Hiromichi Wakui; Tomohiko Kanaoka; Masato Ohsawa; Kengo Azushima; Akinobu Maeda; Hiroyuki Kobori; Satoshi Umemura
Journal:  Hypertens Res       Date:  2012-11-15       Impact factor: 3.872

5.  Augmented circadian rhythm of the intrarenal renin-angiotensin systems in anti-thymocyte serum nephritis rats.

Authors:  Shinsuke Isobe; Naro Ohashi; Sayaka Ishigaki; Takayuki Tsuji; Yukitoshi Sakao; Akihiko Kato; Hiroaki Miyajima; Yoshihide Fujigaki; Akira Nishiyama; Hideo Yasuda
Journal:  Hypertens Res       Date:  2016-01-07       Impact factor: 3.872

6.  Disturbed circadian rhythm of the intrarenal renin-angiotensin system: relevant to nocturnal hypertension and renal damage.

Authors:  Shinsuke Isobe; Naro Ohashi; Tomoyuki Fujikura; Takayuki Tsuji; Yukitoshi Sakao; Hideo Yasuda; Akihiko Kato; Hiroaki Miyajima; Yoshihide Fujigaki
Journal:  Clin Exp Nephrol       Date:  2014-04-12       Impact factor: 2.801

7.  The natriuretic effect of angiotensin receptor blockers is not attributable to blood pressure reduction during the previous night, but to inhibition of tubular sodium reabsorption.

Authors:  Toshiyuki Miura; Shuichi Watanabe; Maki Urushihara; Hiroyuki Kobori; Michio Fukuda
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2014-05-15       Impact factor: 1.636

8.  Proximal tubular angiotensinogen in renal biopsy suggests nondipper BP rhythm accompanied by enhanced tubular sodium reabsorption.

Authors:  Michio Fukuda; Maki Urushihara; Tamaki Wakamatsu; Tadashi Oikawa; Hiroyuki Kobori
Journal:  J Hypertens       Date:  2012-07       Impact factor: 4.844

9.  Comparative efficacy of aliskiren/valsartan vs valsartan in nocturnal dipper and nondipper hypertensive patients: a pooled analysis.

Authors:  Thomas D Giles; Thomas Alessi; Das Purkayastha; Dion Zappe
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-03-16       Impact factor: 3.738

Review 10.  Circadian Control of Sodium and Blood Pressure Regulation.

Authors:  Reham H Soliman; David M Pollock
Journal:  Am J Hypertens       Date:  2021-11-20       Impact factor: 3.080

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.